Protalix BioTherapeutics, Inc. (NYSE:PLX) has 1 institutional investors that have filed 13F reports for the period ending March 2020.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 31 Dec, 2025 | 4,956,352 | 2,375,796 | 92.07% | $8,921,434.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 4,956,352 | 2,375,796 | 92.07% | $8,921,434.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 4,956,352 | 2,375,796 | 92.07% | $8,921,434.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 4,956,352 | 2,375,796 | 92.07% | $8,921,434.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 4,956,352 | 2,375,796 | 92.07% | $8,921,434.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,647,106 | 96,078 | 2.71% | $6,564,791.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,647,106 | 96,078 | 2.71% | $6,564,791.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,647,106 | 96,078 | 2.71% | $6,564,791.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,647,106 | 96,078 | 2.71% | $6,564,791.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,647,106 | 96,078 | 2.71% | $6,564,791.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,616,962 | -30,144 | -0.83% | $7,848,807.00 |
| MAK CAPITAL ONE LLC | 31 Dec, 2025 | 3,544,139 | 3,544,139 | 0.00% | $7,690,782.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,263,300 | -52,100 | -3.96% | $2,273,940.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,263,300 | -52,100 | -3.96% | $2,273,940.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,263,300 | -52,100 | -3.96% | $2,273,940.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,263,300 | -52,100 | -3.96% | $2,273,940.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,263,300 | -52,100 | -3.96% | $2,273,940.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,224,800 | -38,500 | -3.05% | $2,657,816.00 |
| State Street Corp | 31 Dec, 2025 | 972,815 | 387,554 | 66.22% | $2,111,009.00 |
| Northern Trust Corp | 31 Dec, 2025 | 885,448 | 19,740 | 2.28% | $1,921,422.00 |